Exploring novel blood-based DNA methylation biomarkers for alzheimer’s disease via targeted sequencing of highly variable CpG sites
Abstract Objective Dementia, particularly Alzheimer’s disease (AD), continues to be a major public health concern due to population aging, yet minimally invasive biomarkers for early diagnosis have not been established. DNA methylation (DNAm) has recently attracted considerable attention as a promis...
Saved in:
| Main Authors: | Hideki Ohmomo, Shohei Komaki, Shiori Minabe, Yoichi Sutoh, Yayoi Otsuka-Yamasaki, Makoto Sasaki, Atsushi Shimizu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Research Notes |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13104-025-07417-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential DNA methylation biomarkers for the detection of clear cell renal cell carcinoma identified by a whole blood-based epigenome-wide association study
by: Hideki Ohmomo, et al.
Published: (2022-05-01) -
Risk factors and prediction for pediatric obesity: current status and future perspectives
by: Shiori Minabe, et al.
Published: (2025-07-01) -
First Indonesian Nasopharyngeal Cancer Whole Epigenome Sequencing Identify Tumour Suppressor CpG Methylation
by: Handoko, et al.
Published: (2025-01-01) -
Epigenome editing-mediated restoration of FBN1 expression by demethylation of CpG island shore in porcine fibroblasts
by: Rio Miyadai, et al.
Published: (2025-06-01) -
The effect of ApoE e4 on blood pressure in patients with and without depression
by: Hestad K, et al.
Published: (2016-06-01)